These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19176628)

  • 1. Adenovirus serotype 5 L4-22K and L4-33K proteins have distinct functions in regulating late gene expression.
    Morris SJ; Leppard KN
    J Virol; 2009 Apr; 83(7):3049-58. PubMed ID: 19176628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the early-late switch in adenovirus type 5 major late transcription unit expression by L4 gene products.
    Farley DC; Brown JL; Leppard KN
    J Virol; 2004 Feb; 78(4):1782-91. PubMed ID: 14747543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adenovirus L4-33K protein regulates both late gene expression patterns and viral DNA packaging.
    Wu K; Guimet D; Hearing P
    J Virol; 2013 Jun; 87(12):6739-47. PubMed ID: 23552425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus L4-22K stimulates major late transcription by a mechanism requiring the intragenic late-specific transcription factor-binding site.
    Backström E; Kaufmann KB; Lan X; Akusjärvi G
    Virus Res; 2010 Aug; 151(2):220-8. PubMed ID: 20621673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adenovirus L4-22K protein has distinct functions in the posttranscriptional regulation of gene expression and encapsidation of the viral genome.
    Guimet D; Hearing P
    J Virol; 2013 Jul; 87(13):7688-99. PubMed ID: 23637408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human adenovirus 5 L4 promoter is activated by cellular stress response protein p53.
    Wright J; Leppard KN
    J Virol; 2013 Nov; 87(21):11617-25. PubMed ID: 23966406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cellular protein kinases, DNA-PK and PKA, phosphorylate the adenoviral L4-33K protein and have opposite effects on L1 alternative RNA splicing.
    Törmänen Persson H; Aksaas AK; Kvissel AK; Punga T; Engström Å; Skålhegg BS; Akusjärvi G
    PLoS One; 2012; 7(2):e31871. PubMed ID: 22363758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-association of the adenoviral L4-22K protein.
    Yang TC; Maluf NK
    Biochemistry; 2010 Nov; 49(45):9830-8. PubMed ID: 20925313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of human adenovirus alternative RNA splicing by the adenoviral L4-33K and L4-22K proteins.
    Biasiotto R; Akusjärvi G
    Int J Mol Sci; 2015 Jan; 16(2):2893-912. PubMed ID: 25636034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the L4 33K gene in adenovirus infection.
    Fessler SP; Young CS
    Virology; 1999 Oct; 263(2):507-16. PubMed ID: 10544122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine 192 in the tiny RS repeat of the adenoviral L4-33K splicing enhancer protein is essential for function and reorganization of the protein to the periphery of viral replication centers.
    Östberg S; Törmänen Persson H; Akusjärvi G
    Virology; 2012 Nov; 433(2):273-81. PubMed ID: 22944109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for the L1-52/55K protein in the serotype specificity of adenovirus DNA packaging.
    Wohl BP; Hearing P
    J Virol; 2008 May; 82(10):5089-92. PubMed ID: 18337584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Human Adenovirus Type 5 L4 Promoter Is Negatively Regulated by TFII-I and L4-33K.
    Wright J; Atwan Z; Morris SJ; Leppard KN
    J Virol; 2015 Jul; 89(14):7053-63. PubMed ID: 25926634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A suppressive effect of Sp1 recruitment to the first leader 5' splice site region on L4-22K-mediated activation of the adenovirus major late promoter.
    Lan S; Östberg S; Punga T; Akusjärvi G
    Virus Res; 2015 Dec; 210():133-40. PubMed ID: 26247419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adenovirus L4-22K protein is multifunctional and is an integral component of crucial aspects of infection.
    Wu K; Orozco D; Hearing P
    J Virol; 2012 Oct; 86(19):10474-83. PubMed ID: 22811519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus late-phase infection is controlled by a novel L4 promoter.
    Morris SJ; Scott GE; Leppard KN
    J Virol; 2010 Jul; 84(14):7096-104. PubMed ID: 20444889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of adenovirus major late gene expression at multiple levels.
    Larsson S; Svensson C; Akusjärvi G
    J Mol Biol; 1992 May; 225(2):287-98. PubMed ID: 1593621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Role for the Adenovirus L4 Region 22K and 33K Proteins in Adeno-Associated Virus Production.
    Adsero A; Chestnut B; Shahnejat-Bushehri S; Sasnoor L; McMurphy T; Swenor M; Pasquino R; Pradhan A; Hernandez V; Padegimas L; Dismuke D
    Hum Gene Ther; 2024 Jan; 35(1-2):59-69. PubMed ID: 38062776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucine residues in conserved region of 33K protein of bovine adenovirus - 3 are important for binding to major late promoter and activation of late gene expression.
    Kulshreshtha V; Islam A; Ayalew LE; Tikoo SK
    Virology; 2015 Sep; 483():174-84. PubMed ID: 25974868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L4-33K, an adenovirus-encoded alternative RNA splicing factor.
    Törmänen H; Backström E; Carlsson A; Akusjärvi G
    J Biol Chem; 2006 Dec; 281(48):36510-7. PubMed ID: 17028184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.